Zhang Jing, Wu Yongya, Zhang Shuai, Yao Wenmo, Bu Faqian, Wang Aoxue, Hu Xiuying, Wang Guan
Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University /West China School of Nursing, Sichuan University, Chengdu, China.
Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University /West China School of Nursing, Sichuan University, Chengdu, China
BMJ Open. 2024 Mar 11;14(3):e074854. doi: 10.1136/bmjopen-2023-074854.
To evaluate the quality and analyse the content of clinical practice guidelines regarding central venous catheter-related thrombosis (CRT) to provide evidence for formulating an evidence-based practice protocol and a risk assessment scale to prevent it.
Scoring and analysis of the guidelines using the AGREE II and AGREE REX scales.
Pubmed, Embase, Cochrane Library, Web of Science, CNKI, Wanfang, VIP, and the Chinese Biomedical Literature, and the relevant websites of the guideline, were searched from 1 January 2017 to 26 March 2022.
Guidelines covering CRT treatment, prevention, or management were included from 1 January 2017 to 26 March 2022.
Three independent reviewers systematically trained in using the AGREE II and AGREE REX scales were selected to evaluate these guidelines.
Nine guidelines were included, and the quality grade results showed that three were at A-level and six were at B-level. The included guidelines mainly recommended the prevention measure of central venous CRT from three aspects: risk screening, prevention strategies, and knowledge training, with a total of 22 suggestions being recommended.
The overall quality of the guidelines is high, but there are few preventive measures for central venous CRT involved in the guidelines. All preventive measures have yet to be systematically integrated and evaluated, and no risk assessment scale dedicated to this field has been recommended. Therefore, developing an evidence-based practice protocol and a risk assessment scale to prevent it is urgent.
评估关于中心静脉导管相关血栓形成（CRT）的临床实践指南的质量并分析其内容，为制定基于证据的实践方案和预防CRT的风险评估量表提供依据。
使用AGREE II和AGREE REX量表对指南进行评分和分析。
检索2017年1月1日至2022年3月26日期间的PubMed、Embase、Cochrane图书馆、Web of Science、中国知网、万方、维普和中国生物医学文献数据库以及指南的相关网站。
纳入2017年1月1日至2022年3月26日期间涵盖CRT治疗、预防或管理的指南。
选择三名接受过使用AGREE II和AGREE REX量表系统培训的独立评审员对这些指南进行评估。
纳入九条指南，质量分级结果显示，A级三条，B级六条。纳入的指南主要从风险筛查、预防策略和知识培训三个方面推荐了中心静脉CRT的预防措施，共推荐了22条建议。
指南的整体质量较高，但指南中涉及的中心静脉CRT预防措施较少。所有预防措施尚未进行系统整合和评估，也未推荐专门针对该领域的风险评估量表。因此，迫切需要制定基于证据的实践方案和预防CRT的风险评估量表。
